ALX ONCOLOGY HOLDINGS INC (ALXO) Return on equity 2020–2022
ALX ONCOLOGY HOLDINGS INC (ALXO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-46.9%FY2022 · since FY2020: -10.6% → -46.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -46.9% | -23.9 pp |
| FY2021 | -23.0% | -12.3 pp |
| FY2020 | -10.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice